No one can dispute the success of the little blue pill we all call Viagra. It is the most popular prescription medication in the world, but it didn't start out that way. Sildenafil, better known as Viagra, was a hypertension medication when Pfizer developed it in the early 1990s, but clinical tests revealed it had the ability to increase blood flow to the small blood vessel in and around the penis, and the rest as they say is history.
The German pharmaceutical company Boehringer Ingelheim is experiencing a similar situation with Ectris the anti-depressant drug. Several years ago Boehringer introduced Ectris as an anti-depressant, but the first clinical tests on over two thousand women showed that Flibanserin had the ability to increase sexual fantasies and desires in women suffering from some type of female sexual dysfunction (FSD).
The results of those first clinical studies convinced Boehringer to change their marketing strategy from Ectris the anti-depressant to Ectris the female libido enhancer. The company began four clinical studies on the drug in order to apply for FDA approval. Over five thousand women in three hundred and fifty different locations around the world participated in clinical trials and the results have been extremely encouraging.
Boehringer believes that Ectris , the anti-depressant, can be as popular as Viagra and may even have the potential to replace Viagra as the most popular prescription medication in the world once the FDA approves it for medical use. Clinical data shows that women suffering with hypoactive sexual desire disorder and sexual arousal disorder increase their sexually satisfying experiences from three to five a month. Women in the studies also report more sexual fantasies and desires when 100mg of Ectris is used for at least forty weeks.
Ectris the Anti-depressant does Create Some Interesting Side Effects
Ectris the antidepressant turned sexual stimulator has dopamine D4 receptors and serotonin 5-HT receptors as ingredients, and those agents can cause side effects when they enter the body in pill form. Those chemicals are naturally produced in the body, but due to varying hormonal levels those agents can impact the body in different ways.
No one knows how Ectris the ex-antidepressant stimulates the libido, but some researchers believe that an increase in dopamine production and decrease in serotonin production stimulates the central nervous system and the body responds by increasing sexual hormone production even though the ex-antidepressant Ectris is non-hormonal.
Monday, June 21, 2010
Tuesday, June 15, 2010
Ectris could be approved next week by the FDA
Washington: Next week, the FDA will vote on whether the female libido enhancing drug Ectris should be voted in or out. If it could mean a business of 2 million dollars in US markets alone.
The Food and Drug Administration will vote on what's being called 'female viagra', a drug that could be a boon to many women suffering from low sex drives across the globe but is still ensnared by controversy.
The pill is designed to treat a condition identified in an estimated 10 percent to 30 percent of women as hypoactive sexual desire disorder or HSDD - characterised by lack of sexual desire or fantasies, causing emotional distress, a rather vague diagnosis.
The pill, however, comes with side effects, which include insomnia, nausea and dizziness. As always, women will need to decide whether the risks versus the benefits compared to other treatment alternatives are worth it for them.
"What we don't know is what's normal versus what's not normal. You can't label someone who has a low sex drive necessarily as abnormal," CBS News quoted Dr. Bruce Levine of Phoenix OBGYN Associates as saying.
Critics are hammering the drug, saying that customers are being tempted into buying something they don't need and can solve by other inexpensive methods.
"We call that disease mongering, creating a disease when there is no disease in order to sell an expensive product," said Leonore Tiefer of New York University's School of Medicine.
"There are a lot of inexpensive products like a glass of wine or a massage."
"I would say it's definitely improved," said Alicia, who signed for the clinical trial of the drug after being miserable for a long time.
"I find myself initiating things more when I feel like I'm ready to have sex." (ANI)
SEARCH
The Food and Drug Administration will vote on what's being called 'female viagra', a drug that could be a boon to many women suffering from low sex drives across the globe but is still ensnared by controversy.
The pill is designed to treat a condition identified in an estimated 10 percent to 30 percent of women as hypoactive sexual desire disorder or HSDD - characterised by lack of sexual desire or fantasies, causing emotional distress, a rather vague diagnosis.
The pill, however, comes with side effects, which include insomnia, nausea and dizziness. As always, women will need to decide whether the risks versus the benefits compared to other treatment alternatives are worth it for them.
"What we don't know is what's normal versus what's not normal. You can't label someone who has a low sex drive necessarily as abnormal," CBS News quoted Dr. Bruce Levine of Phoenix OBGYN Associates as saying.
Critics are hammering the drug, saying that customers are being tempted into buying something they don't need and can solve by other inexpensive methods.
"We call that disease mongering, creating a disease when there is no disease in order to sell an expensive product," said Leonore Tiefer of New York University's School of Medicine.
"There are a lot of inexpensive products like a glass of wine or a massage."
"I would say it's definitely improved," said Alicia, who signed for the clinical trial of the drug after being miserable for a long time.
"I find myself initiating things more when I feel like I'm ready to have sex." (ANI)
SEARCH
Subscribe to:
Posts (Atom)
